Specifically, we aimed to examine the reasons for GLP-1 RA discontinuation across different time periods and to investigate whether these reasons differ depending on the medications intended usewhether prescribed for weight loss or for diabetes management
Int J Med Aromat Plants 2(2):269274 Salaritabar A, Darvishi B, Hadjiakhoondi F, Manayi A, Sureda A, Nabavi SF, Fitzpatrick LR, Nabavi SM, Bishayee A (2017) Therapeutic potential of flavonoids in inflammatory bowel disease: a comprehensive review
The most common side effect is injection site redness, pain, swelling, or irritation
Any drug that increases the renal secretion of uric acid is classified as a uricosuric
Durantecuntotiempo conservamos sus datos